Alnylam Pharmaceuticals, Inc.

Report date
12/31/2025
Quarter
2025 Q4
Filed
1/30/2026
Shares
44,976
Value ($000)
17,885
Weight
0.1%
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).